ev3 whistleblower awarded $250,000 in FCA settlement

Medical device maker ev3 Inc. agreed to pay $1.25 million to resolve allegations that it caused some hospitals to unnecessarily admit Medicare patients for an outpatient procedure to open hardened arteries, the Justice Department said Thursday.

The civil settlement resolved a lawsuit filed under the whistleblower provisions of the False Claims Act. The law permits private parties to file qui tam suits on behalf of the United States for false claims and obtain a portion of the government’s recovery.

Amanda Cashi, a former Fox Hollow sales representative, filed a qui tam suit against Fox Hollow six years ago. Cashi’s portion of the settlement will be $250,000.

The DOJ alleged that Fox Hollow used 12 hospitals in nine states to submit claims to Medicare for medically unnecessary inpatient stays for some Medicare patients undergoing elective atherectomy procedures.

Atherectomy is a minimally-invasive surgical procedure that uses a small cutting device to remove atherosclerosis, or hardening of the arteries, from large blood vessels. The procedure is intended to open up narrowed coronary arteries to increase blood flow and circulation.

One device used in atherectomies is the Silver Hawk Plaque Excision System sold by Fox Hollow. The DOJ alleged that in 2006 and 2007, Fox Hollow convinced hospitals to bill Silver Hawk atherectomy procedures as more expensive inpatient claims instead of cheaper outpatient claims. Some hospitals did that, and allegedly collected bigger Medicare reimbursement than they were entitled to.

“Medical device makers that try to boost their profits by causing patients to be admitted for unnecessary and expensive inpatient hospital stays will be held accountable,” said Thomas O’Donnell from the inspector general’s office of the federal Department of Health and Human Services. “Both patients and taxpayers deserve to have medical decisions made based on what is medically appropriate.”

Since January 2009, the Justice Department has recovered more than $23.5 billion through False Claims Act cases. More than $15 billion of that amount has been recovered in cases involving fraud against federal health care programs.

The DOJ said the claims resolved by the settlement are allegations only and there has been no determination of liability.

Founder of the FCPA Blog and Editor at Large. He has been named multiple times as one of the 100 Most Influential People In Business Ethics by Ethisphere Magazine and is a Trust Across America Top Thought Leader. He’s a member of the DC, Virginia, and Florida bars. His At Large column is a regular feature of the FCPA Blog.

Legal

Quick Links

About

We set out in 2007 to bring our readers free and unrestricted coverage of all Foreign Corrupt Practices Act enforcement actions — the first to do that in real-time.

Since then we’ve published more than 7,500 posts by 600 different authors.

Our mission is to help compliance professionals and others everywhere understand how corruption happens, what it does to people and institutions, and how anti-corruption laws and compliance programs work.